Ypsomed’s self-injection device track record

Introduction the world’s first autoinjector for prefilled syringes with integrated connectivity.

Introduction of YpsoMate Zero the world's first zero carbon emission prefilled autoinjector.

Introduction of SmartPilot for UnoPen transforming the dial-and-dose UnoPen into a fully connected system.

First FixPen approval and launch for Teriparatide for treating osteoporosis.

Launch of Teva's Ajovy: The world's first approval and launch of a 2.25mL PFS based autoinjector.

Launch of 5 additional YpsoMate 1mL autoinjectors in key markets such as US, EU and JP including Teva's Copaxone and Asahi Kasei's Teribone.

First YpsoMate 1mL approval and launch for Mylan/FKB's Hulio (adalimumab) for the treatment of chronic autoimmune diseases.

Introduction of SmartPilot for YpsoMate transforming the proven YpsoMate autoinjector into a smart product system.

Introduction of an autoinjector suitable for 2.25ml syringes and viscous injection volumes up to 2.25ml. A high power constant force spring is capable to inject highly viscous formulations.

Introduction of an autoinjector suitable for the 2.25ml syringe and injection volumes up to 2.25ml.

Introduction of a customized version of LyoTwist Trio for AstraZeneca’s Bydureon-Pen.

Introduction of a customized version of LyoTwist Trio for GSK’s Tanzeum™/Eperzan^®.

Introduction and first launch of the prefilled UnoPen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance.

Launch of YpsoPen, the intuitive dial & dose reusable pen, for Dongbao's Sulin insulin

Introduction of a new 2-step “buttonless” autoinjector that sets new standards for simplicity and patient feedback. YpsoMate is currently being used by a number of customers for clinical trials in a range of therapeutic indications.

The first reusable automatic insulin pen that won the red dot design award, launched first as Gansulin Pen in China and in customized versions in other markets.

With this new generation of a disposable insulin pen, Ypsomed set a benchmark in the industry.

The world’s first pen for human growth hormone and for dual-chamber cartridges. With this pen Ypsomed built the foundation for pens compatible with dual-chamber cartridges.

As one of the world’s first insulin pens this pen is considered to be one of the forerunners of all following generations of insulin pens.